Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Capricor Therapeutics, Inc. - Common Stock (NQ: CAPR )

13.07 +0.49 (+3.90%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,160,370
Open 12.93
Bid (Size) 12.30 (30)
Ask (Size) 13.21 (1)
Prev. Close 12.58
Today's Range 12.55 - 13.34
52wk Range 3.520 - 23.40
Shares Outstanding 45,469,908
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Capricor Therapeutics’ Retail Chatter Explodes On Stocktwits After FDA Grants Priority Review For DMD Therapy
The health agency has accepted Capricor's Biologics License Application for full approval of deramiocel as a treatment for Duchenne muscular dystrophy cardiomyopathy. 
Via Stocktwits
Exposures Product Safety
Capricor Therapeutics Cell Therapy Goes Under Priority FDA Review For Duchenne Associated-Heart Condition
FDA grants Priority Review to Capricor's deramiocel for Duchenne cardiomyopathy, setting an August 2025 decision date with no identified review issues. 
Via Benzinga
Exposures Product Safety

Performance

YTD
-12.63%
-12.63%
1 Month
-6.24%
-6.24%
3 Month
-8.22%
-8.22%
6 Month
+212.68%
+212.68%
1 Year
+121.53%
+121.53%

More News

Read More
8 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Beyond The Numbers: 7 Analysts Discuss Capricor Therapeutics Stock
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Decoding 12 Analyst Evaluations For Capricor Therapeutics
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
Earnings Preview For Capricor Therapeutics
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,800 Today
Via Benzinga
America's Car-Mart Posts Upbeat Sales, Joins Methode Electronics, Verint Systems, Brown-Forman And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Why Verint Systems Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Space, Biotech, And More: Today’s Hottest Stocks To Watch
Via Talk Markets
Why Capricor Therapeutics (CAPR) Shares Are Trading Lower
Via Benzinga
Forecasting The Future: 9 Analyst Projections For Capricor Therapeutics
Via Benzinga
CSX Posts Weak Earnings, Joins Lucid Group, Nokia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Capricor Therapeutics Says Duchenne Muscular Dystrophy Candidate Shows Sustained Cardiac, Skeletal Benefits After 3 Years
Via Benzinga
Fastenal Posts Upbeat Earnings, Joins Wells Fargo, JPMorgan And Other Big Stocks Moving Higher On Friday
Via Benzinga
PepsiCo, DocuSign, Robinhood And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
MarketBeat Week in Review – 9/30 - 10/4
Via MarketBeat
Topics Economy
Exposures Interest Rates
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Apogee Enterprises Posts Upbeat Earnings, Joins Frontier Group, JetBlue Airways And Other Big Stocks Moving Higher On Friday
Via Benzinga
Nike Reports Weak Sales, Joins Lamb Weston And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
IGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.